NCT02238626 Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT02155829 Safety Study of Riluzole to Treat Post-traumatic Stress Disorder (PTSD) Status COMPLETED Phase PHASE1/PHASE2
NCT02081027 Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Status COMPLETED Phase EARLY_PHASE1
NCT02019940 A Pilot Study Of Riluzole In Patients With Post Traumatic Stress Disorder (PTSD) Status COMPLETED Phase PHASE1
NCT01910259 MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial Status COMPLETED Phase PHASE2
NCT01709149 Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT01661855 A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Status COMPLETED Phase PHASE2
NCT01303341 Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01257828 Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) Status COMPLETED Phase PHASE3
NCT01204918 Efficacy and Tolerability of Riluzole in Treatment Resistant Depression Status COMPLETED Phase PHASE2
NCT01104649 Efficacy of Riluzole in Hereditary Cerebellar Ataxia Status COMPLETED Phase PHASE2/PHASE3
NCT01018836 Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Status TERMINATED Phase PHASE1
NCT01018056 Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission Status COMPLETED Phase PHASE4
NCT00903214 Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Status WITHDRAWN Phase PHASE1